Investigation of Laser Assisted Drug Delivery of NanoDOX®
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
This is a self-controlled single-site study of 10 healthy subjects receiving an ablative
fractional CO2 laser procedure followed by topical application of NanoDOX® Hydrogel (1%
doxycycline). The study includes skin biopsies to evaluate the effects of NanoDOX®
Doxycycline Monohydrate Gel on wound healing after the ablative laser procedure. Study
subjects will be asked to do two visits of approximately 4 hours over two weeks.